{"paper_id":"5dd0fb32-b09e-436c-a888-5be3e0f78fe1","body_text":"Abstract\nPurposes\nIn this study, we sought to establish the value of a new molecule, urocortin (Ucn), in the diagnosis of endometrioma and compare with Ca-125 to identify superiority of urocortin.\nMethods\nOf the patients operated on at our hospital with the initial diagnosis of adnexal mass, 88 patients whose pathology results were endometrioma and benign ovarian cyst were included in the study. As a result of the pathological examination, the patients were assessed in two groups. Group 1 consisted of 42 cases of endometrioma and Group 2 included 46 cases of benign ovarian cyst (control group). The serum Ucn and CA 125 levels of patients were measured from the blood samples drawn prior to the operation.\nResults\nWhile the serum Ucn level was 4.8 ± 1.00 ng/ml in the endometrioma group, it was 4.5 ± 1.03 ng/ml in the control group (P = 0.21). The difference was statistically not meaningful. On the other hand, mean serum Ca-125 level was 43.8 U/l (11.7–251) in the endometrioma group, it was 16.5 U/l (4.3–121.1) in the control group. The difference was statistically meaningful (P = 0.001). When the cut-off point for Serum Ca-125 level was taken as 21.38, sensitivity and specificity levels were found to be 88.1 and 63%. When the cut-off point for Ucn was taken as 4.16, sensitivity was 76.2%, and specificity 45.7%.\nConclusion\nUcn was not found to be efficient in distinguishing endometrioma from other benign ovarian cysts or to be superior to CA125 in the diagnosis of endometrioma.\nSimilar content being viewed by others\nReferences\nEskenazi B, Warner ML (1997) Epidemiology of endometriosis. Obstet Gynecol Clin N Am 24:235–258\nNezhat F, Nezhat C, Allan CJ, Metzger DA, Sears DL (1992) Clinical and histologic classification of endometriomas. Implications for a mechanism of pathogenesis. J Reprod Med 37:77176\nFedele L, Bianchi S, Portuese A, Borruto F, Dorta M (1998) Transrectal ultrasonography in the assessment of rectovaginal endometriosis. Obstet Gynecol 91:444–448\nArrivé L, Hricak H, Martin MC (1989) Pelvic endometriosis: MR imaging. Radiology 171:687–692\nFlorio P, Arcuri F, Ciarmela P, Runci Y, Romagnoli R, Cintorino M, Di Blasio AM, Petraglia F (2002) Identification of urocortin mRNA and peptide in the human endometrium. J Endocrinol 173:R9–R14\nFlorio P, Vale W, Petraglia F (2004) Urocortins in human reproduction. Peptides 25:1751–1757 (review)\nFlorio P, Reis MF, Torres PB, Calonaci F, Toti P, Bocchi C et al (2007) Plasma urocortin levels in the diagnosis of ovarian endometriosis. Obstet Gynecol 110:594–600\nDuleba AJ (1997) Diagnosis of endometriosis. Obstet Gynecol Clin N Am 24:331–346\nKoninckx PR, Meuleman C, Oosterlynck D, Cornillie FJ (1996) Diagnosis of deep endometriosis by clinical examination during menstruation and plasma CA-125 concentration. Fertil Steril 65:280–287\nPittaway DE, Fayez JA (1987) Serum CA-125 antigen levels increase during menses. Am J Obstet Gynecol 156:75–76\nBrosens J, Timmerman D, Starzinski-Powitz A, Brosens I (2003) Non-invasive diagnosis of endometriosis: the role of imaging and markers. Obstet Gynecol Clin N Am 30:95-ix\nPittaway DE, Fayez JA, Douglas JW (1987) Serum CA-125 in the evaluation of benign adnexal cysts. Am J Obstet Gynecol 157:1426–1428\nMuramatsu Y, Sugino N, Suzuki T, Totsune K, Takahashi K, Tashiro A et al (2001) Urocortin and corticotropin releasing factor receptör expression in normal cycling human ovaries. J Clin Endocrinol Metab 86:1362–1369\nTorricelli M, De Falco G, Florio P, Rossi M, Leucci E, Vigano P et al (2007) Secretory endometrium highly expresses urocortin messenger RNA and peptide: possible role in the decidualization process. Hum Reprod 22:92–96\nLatchman D (2002) Molecules in focus urocortin. Int J Biochem Cell Biol 34:907–910\nLewis K, Li C, Perrin MH, Blount A, Kunitage K, Donaldson C et al (2001) Identification of urocortin III, an additional member of the CRF family with high affinity for CRF2 receptor. Proc Natl Acad Sci USA 98:7570–7575\nNg LL, Loke IW, O’Brien RJ, Squire IB, Davies JE (2004) Plasma urocortin in human systolic heart failure. Clin Sci 106:383–388\nFlorio P, Torricelli M, De Falco G, Leucci E, Giovannelli A, Gazzalo D et al (2006) High maternal and fetal plasma urocortin levels in pregnancies complicated by hypertension. J Hypertens 24:1831–1840\nToricelli M, Ignacchiti E, Giovannelli A, Merola A, Scarpetti E, Calonaci G et al (2006) Maternal plasma corticotrpin-releasing factor and urocortin levels in post-term pregnancies. Eur J Endocrinol 154:281–285\nConflict of interest statement\nThe authors have no conflicts of interest.\nAuthor information\nAuthors and Affiliations\nCorresponding author\nRights and permissions\nAbout this article\nCite this article\nTokmak, A., Ugur, M., Tonguc, E. et al. The value of urocortin and Ca-125 in the diagnosis of endometrioma. Arch Gynecol Obstet 283, 1075–1079 (2011). https://doi.org/10.1007/s00404-010-1505-2\nReceived:\nAccepted:\nPublished:\nIssue date:\nDOI: https://doi.org/10.1007/s00404-010-1505-2","source_license":"CC0","license_restricted":false}